Shareholders will be ecstatic, with their stake up 23% over the past week following Sensus Healthcare, Inc.'s (NASDAQ:SRTS) latest annual results. It was overall a positive result, with revenues beating expectations by 2.1% to hit US$24m. Sensus Healthcare also reported a statutory profit of US$0.03, which was a nice improvement from the loss that the analysts were predicting. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

Check out our latest analysis for Sensus Healthcare

Taking into account the latest results, the most recent consensus for Sensus Healthcare from four analysts is for revenues of US$28.3m in 2024. If met, it would imply a decent 16% increase on its revenue over the past 12 months. Statutory per-share earnings are expected to be US$0.03, roughly flat on the last 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$28.7m and earnings per share (EPS) of US$0.052 in 2024. So there's definitely been a decline in sentiment after the latest results, noting the pretty serious reduction to new EPS forecasts.

Despite cutting their earnings forecasts,the analysts have lifted their price target 19% to US$7.13, suggesting that these impacts are not expected to weigh on the stock's value in the long term. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Sensus Healthcare at US$8.00 per share, while the most bearish prices it at US$6.00. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Sensus Healthcare is an easy business to forecast or the the analysts are all using similar assumptions.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's clear from the latest estimates that Sensus Healthcare's rate of growth is expected to accelerate meaningfully, with the forecast 16% annualised revenue growth to the end of 2024 noticeably faster than its historical growth of 9.5% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 7.9% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Sensus Healthcare is expected to grow much faster than its industry.